Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2012 / Article
Special Issue

Redox Biology of Exercise

View this Special Issue

Research Article | Open Access

Volume 2012 |Article ID 920932 | https://doi.org/10.1155/2012/920932

Emily D. Lamprecht, Carey A. Williams, "Biomarkers of Antioxidant Status, Inflammation, and Cartilage Metabolism Are Affected by Acute Intense Exercise but Not Superoxide Dismutase Supplementation in Horses", Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 920932, 15 pages, 2012. https://doi.org/10.1155/2012/920932

Biomarkers of Antioxidant Status, Inflammation, and Cartilage Metabolism Are Affected by Acute Intense Exercise but Not Superoxide Dismutase Supplementation in Horses

Academic Editor: Manfred Lamprecht
Received17 Mar 2012
Accepted06 May 2012
Published08 Aug 2012


Objectives were to evaluate effects of (1) repetitive arthrocentesis on biomarkers of inflammation (prostaglandin E2, PGE2) and aggrecan synthesis (chondroitin sulfate-846; CS) in synovial fluid (SF); (2) exercise and superoxide dismutase (SOD) supplementation on biomarkers of inflammation, antioxidant status, and aggrecan synthesis, in horses. Preliminary trial. Standardbreds underwent four arthrocentesis procedures within 48 h and exhibited elevated CS and no changes in PGE2. Exercise trial. this randomized crossover design used twelve Standardbred mares which received either treatment (3000 IU d−1 oral SOD powder) or placebo (cellulose powder) for 6 wks which culminated with them running a repeated sprint exercise test (RSET). Samples were collected before (PRE), during (PEAK), and following exercise (POST). Exercise resulted in increased ( ) antioxidant defenses including erythrocyte SOD, total glutathione, glutathione peroxidase, gene transcripts for interferon-gamma, interleukin-10, and interleukin-1β in blood, and decreased plasma nitric oxide. Exercise increased ( ) SF CS and adjusted-PGE2, and higher ( ) CS and PGE2 were found in hock versus carpus joints. No treatment effects were detected. Results suggest normal adaptive responses likely due to exercise-induced tissue microdamage and oxidative stress. Additional research is needed to identify benefit(s) of SOD supplementation in horses.

1. Introduction

Equine athletes suffer from challenges of the immune system and inflammation related to exercise [14]. Intense physical activity has been shown to induce subclinical tissue damage and a subsequent immune response involving the upregulation of inflammatory mediators termed cytokines. Exercise-induced increases in cytokine transcripts including tumor necrosis factor alpha (TNFα), interleukin-1 beta (IL-1β), interferon gamma (IFNγ), interleukin-6 (IL-6), and interleukin-10 (IL-10) are comparable to that of an acute phase immune response and have been demonstrated in horses [5, 6]. Furthermore, inflammatory processes have also been associated with redox imbalances favoring pro-oxidants, resulting in oxidative stress [7]. Exercise-induced increases in the generation of reactive oxygen species (ROS), including, free radicals have also been demonstrated in horses [6, 812]. Over exaggerated or sustained responses to intense exhaustive exercise may set the stage for a chronic inflammatory and/or an immunosuppressed state and a predisposition to infection, poor physical performance, and/or onset of chronic diseases [13, 14].

Specifically, degenerative joint disease is a major concern to the equine industry. Joint discomfort in horses is the most common cause of lameness, diminished athletic performance and quality of life, economic burden, and animal loss [1518]. Due to high rates of morbidity and mortality related to arthropathies, biomarkers indicative of early changes related to the development of joint disease have been identified, providing an opportunity to detect and mitigate the disease process early on. Prostaglandin E2 (PGE2) is a prostanoid important for the maintenance of local homeostasis, mediation of inflammation, and sensitization to pain [19, 20]. Elevated PGE2 concentration in synovial fluid is considered an indicator of synovitis [21, 22] and a predictor of equine joint disease [2]. The CS-846 epitope (CS) is found on fragments of newly synthesized aggrecan that have been released from the cartilage matrix [23] and can serve as a biomarker for cartilage metabolism, specifically aggrecan synthesis, in equine joints [21, 22, 24].

Identification of nutritional interventions which are effective in supporting resilience to exercise-induced inflammation and oxidative stress is needed. Most nutritional supplements are intended to decrease onset, severity or progression of disease symptoms, but lack controlled research. With verification of safety and efficacy in the target specie, nutritional interventions may provide practical and less cost-prohibitive options compared to other medical or pharmacological therapies [25, 26]. Furthermore, the use of orally available antioxidant enzymes may have an advantage over nonenzymatic supplements, because they catalyze the detoxification of their ROS substrates in a disproportionate manner, instead of getting stoichiometrically consumed like exogenous antioxidant substrates [26].

Superoxide dismutases (SOD) are enzymatic antioxidant defenses which catalyze the dismutation of superoxide ions into oxygen and hydrogen peroxide. Studies reporting the successful use of antioxidant enzymes as dietary interventions are increasing. Furthermore, there are several reports indicating that supplementation with exogenous SOD is effective in reducing proinflammatory cytokines and inhibiting neutrophil infiltration to sites of tissue damage in several inflammation models [27, 28]. Exogenous SOD has been used in various forms, as an oral supplement [2931], topical treatment [32], and injectable therapy [33, 34]. Effectiveness in modifying systemic inflammatory responses, antioxidant status, and chondroprotective effects in diarthrodial joints, following oral supplementation in horses, remains to be investigated. Therefore, the purpose of this study was to evaluate the effect(s) of oral SOD supplementation in horses following intense exhaustive exercise. Objectives of the current study were as follows: (1) to evaluate the effects of repeated arthrocentesis within a 48 h time frame on markers of inflammation and cartilage metabolism in synovial fluid of healthy horses at rest and (2) to evaluate the effects of a single bout of intense exhaustive treadmill exercise and exogenous SOD supplementation on biomarkers of inflammation, antioxidant status, and anabolic cartilage metabolism in healthy horses.

2. Materials and Methods

2.1. Subjects

A sample of 12 healthy, unfit Standardbred mares aged  yr, weighing kg, with lameness scores of (on a scale of 0–5, with 5 being non-weight bearing; [35]), body condition scores of (on a scale of 1–9, with 1 being emaciated and 9 being morbidly obese; [36]), and per cent body fat at % [37] were used in this study. Mares were housed in New Jersey at the Rutgers University Equine Exercise Physiology Laboratory on 2-acre exercise lots and were provided ad libitum access to moderate quality grass hay, water, and salt. They also received 1 kg of a 10% crude protein sweet feed (Nutrena Vitality, Cargill Inc., Minneapolis, MN, USA) twice daily to meet maintenance requirements. All animal procedures described herein have been approved by the Rutgers University Institutional Animal Care and Use Committee. Aspects of the experimental design were approved retrospectively.

2.2. Preliminary Trial

The objective of this preliminary trial was to evaluate effects of repeated arthrocentesis within a 48 h time frame on a marker of inflammation and anabolic cartilage metabolism in synovial fluid of healthy horses at rest. Synovial fluid samples were collected from 6 randomly selected mares out of the sample population previously described. Aseptic arthrocentesis was performed on the same radiocarpal joint space in each horse on four occasions within a 48 h time frame at the following intervals-initial joint tap ( ), second joint tap 24 h following the initial tap ( ), third tap 26 h following the initial tap ( ), and a fourth tap 48 h following the initial tap ( ). Mares were mildly sedated with 0.3–0.5 mL of detomidine hydrochloride (10 mg mL−1) intravenously, 10 min prior to each arthrocentesis procedure. The synovial fluid was initially collected into sterile syringes using sterile 20 gauge one inch hypodermic needles, and then immediately transferred to pre-chilled 10 mL tubes containing ethylenediaminetetraacetic acid (EDTA) and placed on ice. Samples were centrifuged for 20 min at 1500  g to remove any cellular debris, aliquoted and stored at −80˚C for later analysis of PGE2 (R&D Systems Parameter High-Sensitivity PGE2 Assay, Minneapolis, MN, USA; Intra-assay CV = 18.0% Interassay CV = 13.9%; [38]) and CS (Aggrecan CS-846 Epitope ELISA, IBEX Pharmaceuticals Inc., Montreal, Quebec, Canada; Intra-assay CV = 3.1%; Interassay CV = 8.1%; [24]) according to manufacturer’s instructions.

2.3. Exercise Trial

This study was conducted as a placebo controlled randomized crossover design to evaluate the effects of a single bout of intense exhaustive treadmill exercise and exogenous SOD supplementation on biomarkers of inflammation, antioxidant status, and anabolic cartilage metabolism in healthy horses. Mares were randomly assigned to either a treatment group (TRT) or placebo group (CON). The TRT group received 3 g/d (3000 IU of enzyme activity) of a proprietary oral formulation of SOD powder extracted from cantaloupe melon and chemically combined with wheat gliadin (vegetal hydrophobic biopolymer). The SOD supplement was verified prior to the study, to provide a minimum of 1000 IU of enzyme activity per gram of powder, using a nitro blue tetrazolium reduction method previously described [39]. The CON group received 3 g/d of a microcrystalline cellulose powder. Both TRT and CON groups received their supplement top dressed on their morning grain ration and all investigators were blind to the treatments. The initial phase of the study consisted of a 42 d supplementation period which concluded with a repeated sprint exercise test (RSET), previously determined to influence biomarkers of inflammation and antioxidant status in horses [6]. Mares then completed a 42 d washout period, the experimental groups were crossed over and an identical 42 d supplementation period and RSET were completed. Before each phase of the study, standardized methods were used to evaluate each mare for body condition [36], orthopedic soundness [35], and per cent body fat [37].

Exercise Protocol
The RSET lasted an average of 18.4 0.7 min and began with 2.5 min of walking at 1.5 m s−1 followed by 4 min of trotting at 4 m s−1. Following warm up, mares completed 2 min sprints at 7, 8, 9, and 10 m s−1 with 2 min of walk at 1.5 m s−1 between each sprint [40, 41]. Mares ran to fatigue or until the test was completed, at which time they spent 1 min walking at 1.5 m s−1. Fatigue was defined as an inability of the mares to keep up with the treadmill despite humane encouragement.

2.4. Sampling and Analysis

Synovial Fluid
Samples were taken 24 h before exercise (PRE), 30 min, 2 h, and 24 h after exercise (POST). Samples were collected via aseptic arthrocentesis from one radiocarpal and one tibiotarsal joint space as described above for the preliminary trial, and placed into prechilled 10 mL tubes containing EDTA and immediately placed back on ice. The SF was centrifuged for 20 min at 1500  g to remove any cellular debris, aliquoted and stored at −80˚C for later analysis of CS and PGE2 using commercial ELISA kits, as described above.

Venous Blood
Samples were collected relative to the RSET, before exercise (PRE), at completion of the sprint portion of the RSET (PEAK), 30 min, 2, 4, 24, and 36 h after exercise (POST). Blood was collected using an indwelling jugular catheter and placed into prechilled 10 mL tubes containing sodium heparin, another 10 mL tube containing EDTA, and 10 mL serum separator tubes containing clot activator and gel for serum separation (Vacutainer, Becton Dickinson, Franklin Lakes, NJ, USA). Heparinized tubes were placed back on ice and immediately analyzed for packed cell volume (Hct) using microhematocrit technique (CritSpin S-120, Iris Sample Processing, Westwood, MA, USA) and were centrifuged for 10 min at 1500  g at 4˚C. The plasma fraction was then analyzed for total protein (TP) using digital refractometry (Palm Abbe Veterinary Refractometer, MISCO Inc., Cleveland, Ohio, USA). Serum tubes remained at room temperature for approximately 1 h to allow for blood clotting and were centrifuged for 20 min at 1500  g at 10˚C. Plasma and serum fractions were aliquoted and frozen at −80˚C for later analysis. Blood components were analyzed for plasma lactate (LA; YSI Sport 1500, YSI Inc. Life Sciences, Yellow Springs, Ohio, USA; intra-assay CV = 0.79%; interassay CV = 0.72%), serum creatine kinase (CK; VetTest CK Slides; VetTest 8008 analyzer, IDEXX Laboratories Inc., Westbrook, MA, USA; intra-assay CV = 1.39%; interassay CV = 1.29%), plasma total nitrite as an indicator of nitric oxide (NO; BioAssay Systems, Hayward, CA, USA; intra-assay CV = 4.7%; interassay CV = 7.96%; [42]), and serum CS (as described above for the preliminary trial). All assays were run according to manufacturer’s instructions.

Erythrocyte Lysate
For assays utilizing erythrocyte lysate, 500 μL whole blood from a sodium heparin collection tube was transferred to a microcentrifuge tube and was centrifuged at 2500 g for 5 min at 4˚C. The plasma supernatant was discarded and the remaining erythrocytes were washed with 500 μL of sterile 0.9% sodium chloride solution, thoroughly vortexed and centrifuged a second time as described above. The saline supernatant was carefully removed and discarded from the sample, and the remaining erythrocytes were lysed with 1 mL of ice-cold distilled deionized water. Erythrocyte lysate was aliquoted and stored at −80˚C within 20 min of collection, for later analysis of SOD activity (SOD Assay Kit-WST, Dojindo Molecular Technologies Inc., Rockville, MD, USA; interassay CV = 13.7%; [43]), hemoglobin concentration (QuantiChrom 92 Hemoglobin Assay Kit, BioAssay Systems, Hayward, CA, USA; [44]), glutathione peroxidase activity (GPx; OxisResearch, Foster City, CA, USA; intraassay CV = 0.99%; interassay CV = 10.8%; [45]), and total glutathione (GSH-T; OxisResearch, Foster City, CA, USA; intraassay CV = 1.1%; interassay CV = 1.2%; [46]), all according to manufacturer’s instructions.

RNA Collection
Blood was also collected by means of jugular puncture into PAXgene blood RNA collection tubes (Qiagen/Becton Dickinson, Valencia, CA, USA) containing quaternary amine surfactants at PRE, 30 min, 2 h, and 24 h POST sample times. Total RNA was collected from 2.5 mL of whole blood according to manufacturer’s instructions and the RNA was quantified using a spectrophotometer (Biophotometer, Eppendorf, Westbury, NY, USA). The RNA purity and quantity in each extraction were found to be sufficient for gene expression analysis and amplification efficiencies were between 1.8 and 2.2. A detailed description of RNA preparation, reverse transcription, and amplification was described previously [47]. Relative quantification (2-ΔΔCT method) was used to analyze the changes in gene expression [48, 49]. Cytokine (target) gene expression was normalized to that of the endogenous control gene beta-glucuronidase (β-GUS) and fold changes in target gene expression were calculated relative to a calibrator sample (mean resting baseline) within each data set. Amplification efficiency variation was taken into account and corrected for using the LinReg 7.0 software [50]. The following cytokine transcripts were measured: tumor necrosis factor alpha (TNFα; pro-inflammatory), interleukin-1 beta (IL-1β; pro-inflammatory), interferon gamma (IFNγ; immunomodulatory), interleukin-6 (IL-6; multifunctional), and interleukin-10 (IL-10; anti-inflammatory). Equine cytokine primer and probe sequences and PCR amplicon fragment sizes were previously published [6].

Statistical Analysis
For the preliminary trial, data are presented as the mean ± SE and analyzed using a MIXED model ANOVA with repeated measures in SAS to evaluate effects of repeated arthrocentesis sampling. Significant main effects were further analyzed using Tukey-Kramer post hoc analysis to further elucidate significant changes as inferred when .
For the exercise trial, cytokine data are presented as relative mRNA transcripts (RMT) or the mean fold changes in target gene expression normalized to an endogenous control gene (β-GUS) and relative to that of a calibrator sample (resting, presupplementation baseline) in response to intense exercise SE. All other data are summarized as the mean SE. Data were analyzed using a MIXED model ANOVA with repeated measures in SAS 9.1 to evaluate effects of SOD supplementation (TRT versus CON), acute exercise (as sample time), joint space (as carpus and hock; for synovial fluid parameters), and interactions. Horse was nested within treatment as the subject, and sample time was designated as the repeated effect. The Satterthwaite approximation of standard errors was utilized to account for any unequal variances. Significant main effects were further analyzed using Tukey-Kramer post hoc analysis to further elucidate significant changes as inferred when . Pearson’s product moment correlation was used to test for associations between the variables measured and only significant associations were reported.

3. Results

3.1. Preliminary Trial

Effect of repeated arthrocentesis was detected for CS ( ; Table 1) where synovial fluid concentrations were higher ( ) at ( ) when compared to ( ) and ( ). No differences ( ) in concentrations of CS were detected between ( ) and ( ). Differences between sampling times for PGE2 ( ; Table 1) were not detected.


CS, ng mL−1
PGE2, pg mL−1

3.2. Exercise Trial

Response to Exercise
There were no TRT effects detected for any parameter measured ( ). A main effect of exercise ( ) was detected for Hct, plasma TP, plasma LA, and serum CK, where maximal values occurred at PEAK during exercise (Table 2).

VariablePrePeak30 min POST2 h POST4 h POST24 h POST36 h POST

Hct, %
TP, g dL−1
LA, mmol L−1
CK, U L−1

Biomarkers of Antioxidant Status
The RSET did influence SOD activity ( ), GPx activity ( ), GSH-T ( ), and NO ( ). Erythrocyte SOD activity increased from PRE to PEAK ( ) followed by a decrease ( ) to preexercise activity at 30 min POST (Figure 1(a)). Erythrocyte GPx activity was higher ( ; Figure 1(b)) at PEAK when compared to other time points, and returned to preexercise activity by 30 min POST. Similar to GPx, erythrocyte GSH-T was also highest ( ; Figure 1(c)) at PEAK compared to other samples times, and gradually returned to preexercise values by 4 h POST. Plasma NO decreased ( ; Figure 1(d)) from 30 min POST to 24 h POST and returned to PRE values at 36 h POST.

Biomarkers of Systemic Inflammatory Response
The RSET influenced IFNγ ( ), IL-1β ( ), and IL-10 ( ) transcripts; however, there was no effect of sample time on IL-6 or TNFα gene expression ( ). Interferon gamma transcripts increased ( ; Table 3) from PRE to PEAK and decreased ( ) to preexercise levels at 2 h POST. Gene expression for IL-1β was higher at 2 h POST ( ; Table 3) when compared to PRE, 30 min and 24 h POST samples. Transcripts for IL-10 also tended to increase ( ; Table 3) from PRE to PEAK and then decreased ( ) from PEAK to 24 h POST returning to pre-exercise values. Correlations were detected and can be found in Table 4.

Pre30 min Post2 h Post24 h Post

IL-1β, RMT
IL-10, RMT

HctaTPaLAaCKbcGPxcGSH-TcNOcdIFNγ dIL-1β dIL-10dTNFα dIL-6d









Biomarkers of Joint Health
For CS concentrations, there were main effects of exercise ( ) in serum samples, as well as main effects of exercise ( ) and joint ( ) for CS in synovial fluid. Further data analysis revealed lower ( ) serum concentrations of CS at 30 min and 2 h POST samples when compared to 24 h POST. Synovial fluid concentrations of CS were elevated ( ) at 30 min POST compared to PRE and 2 h POST samples, and when compared to all other sample times, synovial fluid CS was higher ( ) at 24 h POST (Figure 2(a)). Hock joints were found to have higher ( ) concentrations of CS when compared to carpus joints (Figure 2(a)).

Main effects for PGE2 concentrations in synovial fluid were not detected ( ); however, after adjusting the data by subtracting the PRE value from each POST value, and evaluating changes relative to pre-exercise values, effects of exercise ( ) and joint ( ) were detected (Figure 2(b)). The relative increase in PGE2 at 24 h POST was greater than that at PRE ( ) and demonstrated a trend for being greater ( ) when compared to relative changes at the 30 min POST sample time (Figure 2(b)). Similar to synovial fluid CS concentrations, there were greater relative increases ( ) in PGE2 concentrations in hock joints when compared to carpus joints (Figure 2(b)).

4. Discussion

4.1. Effect of Repeated Arthrocentesis

The impact of repeated arthrocentesis on biomarkers of inflammation and joint health are conflicting in the literature. Therefore, the primary objective of the preliminary trial was to identify possible confounding factors arising from the specific repeated arthrocentesis protocol that was implemented in the subsequent exercise trial, in a sample population of healthy horses. Data from this trial indicated that repeated synovial fluid sampling did not elicit a detectable inflammatory response based upon statistically similar PGE2 concentrations, but may have mildly impacted aggrecan turnover as evidenced by elevated CS at the last sample time. These data are in partial contrast to a previous study which demonstrated increases in synovial fluid concentrations of PGE2 and nitric oxide following 2 consecutive joint taps with a 12-hour interval between taps, when compared to baseline values [51]. Increases in glycosaminoglycans (GAG) were also detected in radiocarpal and tarsocrural joints after 2 consecutive taps with a 60 hour interval between taps, in mature healthy horses. Another study reported increased matrix metalloproteinase-1, a biomarker for tissue remodeling, in equine synovial fluid, following repeated arthrocentesis within a 60 h time-frame [52]. These findings are in partial contrast to additional reports in the literature. A previous study [6] did not find a repetitive arthrocentesis protocol, similar to the present trial’s, to modulate synovial fluid concentrations of nitric oxide, in radiocarpal and tibiotarsal joints of mature, healthy mares following intense exhaustive treadmill exercise. Another study reported no effect of repeated synovial fluid sampling (4 taps over 10 days with intervals ranging from 12 h to 168 h between taps) on the pro-inflammatory regulator TNFα, in synovial fluid of normal equine joints [53]. Furthermore, a study where healthy horses underwent weekly synovial fluid aspiration for a total of 13 wks did not report evidence of repeated sampling effects on keratin sulfate or CS in control radiocarpal joints [54]. Authors of a similar study, during which healthy young horses underwent repeated arthrocentesis for several weeks, concluded that any effects of the repeated synovial fluid sampling were minor and most likely did not confound experimental data [22]. Relative to the preliminary trial, the specific arthrocentesis protocol that was executed did not appear to influence PGE2 at any sample time, although aggrecan synthesis may have been impacted, indicated by mildly elevated CS concentrations at the last sampling time, and should be taken into consideration when interpreting similar data from the exercise trial.

4.2. Response to Exercise

The RSET was strenuous enough to elicit increases in muscle enzymes, pro- and anti-inflammatory cytokine gene transcripts, as well as markers of antioxidant status, discussed below. Normal increases in Hct and TP from PRE to PEAK samples were expected findings in the present study and are consistent with previous studies evaluating hematologic and plasma biochemical measurements in exercising horses [55, 56].

The LA increase during and after exercise in the present study indicates that mares were working at a velocity consistently above their anaerobic threshold and in a state where the lactate efflux mechanism was saturated. Lactate response in the present study was positively correlated with CK, pro-inflammatory cytokine IFNγ and TNFα transcripts, as well as the anti-inflammatory cytokine IL-10, which further demonstrates that the type and intensity of the RSET was a determinant of the systemic inflammatory response. Supplementation with a nutraceutical blend containing SOD has been shown to be beneficial in humans, resulting in an improvement in the velocity at which lactate threshold is reached during intense exercise [30]; however this was not seen in the present study.

Elevated PEAK CK values in the present study are comparable to those of horses having engaged in racing and training regimes intense enough to induce overtraining syndrome [57]. Exercise-induced increases in CK in the present study may indicate increased myocyte membrane permeability [58], which was not attenuated by SOD supplementation. Increases in CK have also been positively correlated with increases in ROS formation and subsequent increases in lipid peroxidation in horses [11, 59, 60]. Therefore, it is plausible that exercise-induced increases in ROS may influence myocyte membrane permeability permitting the muscle enzymes to enter circulation [61]. Creatine kinase was also positively correlated with IFNγ and IL-10 in the current study, suggesting that changes in myocyte integrity, resulting from exercise and increased ROS production, coincide with a pro-inflammatory immune response.

Systemic Inflammatory Response
Increases in pro-inflammatory cytokine transcripts at PEAK and sample times following the RSET indicate a pro-inflammatory response to exercise and a counter anti-inflammatory response. These physiological changes are most likely in response to incurred tissue microdamage, increased ROS generation, and possibly mild endotoxemia following the intense, exhaustive exercise test, although direct measurements of neutrophilia and circulating endotoxin were not quantified in the present study.
Positive correlations detected between the cytokines evaluated in the present study further illustrate the close relationships between these cytokines. For example, IFNγ is considered a pro-inflammatory cytokine that serves to activate macrophages, augment the synthesis of other pro-inflammatory cytokines, and induce nitric oxide synthase and ROS formation [49, 62]. The pro-inflammatory response also signals anti-inflammatory cytokines, such as IL-10, which is also thought to possess antioxidant properties. Interleukin-10 inhibits several cytokines including IFNγ, IL-1β, TNFα, and IL-6, mainly by initiating the degradation of mRNA for these cytokines as well as the inhibition of antigen presentation [63, 64] and release of ROS [65]. The inhibition of proinflammatory cytokines, NO production, and superoxide anion formation in endothelial tissue [66], can have an impact on neutrophil priming for oxidative burst [67]. Furthermore, antioxidants have been show to upregulate IL-10 in antigen-IgE-activated mast cells in vitro [68].

Changes in Antioxidant Status
In the present study, changes in SOD activity, GPx activity, GSH-T, and a reduction in plasma NO concentrations were detected, indicating that the RSET was effective in eliciting changes in antioxidant defenses and is indirectly suggestive of exercise-induced oxidative stress, although direct analysis of oxidative stress biomarkers was not performed. The authors speculate that increases in SOD, GPx, and GSH-T at PEAK were compensatory responses to exercise-induced oxidative stress in the current study. Several studies have demonstrated similar exercise-induced changes in antioxidant status or oxidative stress after a single bout of intense exercise in humans [6971] and horses [9, 12, 56, 7275], and following a bout of prolonged intense exercise in horses [10, 60].
Alterations in SOD, GPx, and GSH-T in response to exercise vary within the literature. With regard to the current study, GPx and GSH-T were positively correlated and increased as the mares were fatiguing at the end of the RSET. This increase in the antioxidant enzyme and its thiol substrate is in accordance with previous studies reporting similar increases in SOD, GPx, and GSH-T in horses [59, 74], GSH-T and GPx in rat muscle [76], and GSH-T in human plasma [77], either during or following strenuous exercise. Elevations in antioxidant defenses indirectly suggest that the exercise stress increased ROS production. Increased SOD activity suggests generation of superoxide anions, and the increases in GPx and GSH-T indicates increased production, most likely from the metabolism of superoxide by SOD, and subsequent elimination of hydrogen peroxide via oxygenation of reduced glutathione, in the present study. Furthermore, GSH-T and CK were positively correlated in the present study, as has been reported previously [60], suggesting that increasing ROS formation may be altering muscle membrane integrity allowing for increases in circulating muscle enzymes and antioxidant defenses.
In contrast to the present study’s findings, several other studies reported no changes in erythrocyte GPx or GSH-T [12] relative to an acute bout of exercise in horses, reduced erythrocyte GPx activity, and no changes in SOD activity in trained Thoroughbred horses following intense exercise on a race track (1000 m at 15 m s−1; [78]). Decreases in GPx and GSH-T in endurance horses following an 80 km race [79] and a 140 km race [10] have also been reported. It should be noted that the exercise modalities, exercise intensities, duration, and fitness status of the experimental models differ from study to study, and comparison between studies should be made with this in mind. Interestingly, in a majority of the studies that did not report changes in antioxidant defenses, the experimental subjects were exercise trained and fit for their respective exercise test, indicating that antioxidant systems most likely adapt to the specific conditions of regular training [80].
The decrease in plasma NO concentration, along with upregulation of cytokine transcripts following exercise, was comparable to responses noted in previous reports in horses following a single bout of intense exhaustive exercise, with the exception of TNFα and IL-6 transcripts remaining unchanged, in the present study [6, 81]. The decline in NO may be due to increased utilization, increased excretion, and decreased production or bioavailability of NO resulting from increased oxidative stress, in the present study. Plasma NO was positively correlated with pro-inflammatory cytokines IFNγ and TNFα and negatively correlated with GPx in the present study. The inverse relationship of NO to GPx may reflect the increase in ROS and subsequent decrease in NO bioavailability, in conjunction with increased GPx to counter oxidative stress. Exercise-induced generation of superoxide and NO lends to the formation of peroxynitrite a damaging reactive nitrogen species, therefore, reducing NO bioavailability [82]. The positive association of NO with proinflammatory cytokines most likely reflects the postexercise decline in IFNγ and NO in the present study, indicating recovery from exercise-induced inflammation and increased utilization or depletion of NO.

Implications on Joint Health
Healthy articular cartilage serves to distribute load in a pain and friction-free manner. Cartilage consists of specialized cells (chondrocytes) distributed in three distinct layers within an intracellular matrix consisting primarily of proteoglycans and type II collagen [83]. The integrity of the matrix is dependent on chondrocyte metabolism, which has been shown to be influenced by stressors, including shear and compressive strain, which occur with exercise [83]. One study, using normal human and bovine articular chondrocyte culture, demonstrated that fluid-induced shear stimulated glycosaminoglycan (GAG) synthesis, and after 48 h of shear stress PGE2 production was increased when compared to controls [84]. Furthermore, evidence of ROS (specifically superoxide anion) in the joint has been reported [85]. Presence of ROS in joints can lead to proteoglycan cleavage [86], compromising the integrity of the cartilage matrix. The relative increase in PGE2 from PRE to 24 h POST in the exercise trial suggests a slightly delayed onset of inflammation following the RSET. It is plausible that the type of joint loading resulting from the RSET in the current study induced enough fluid-induced shear and change in hydrostatic pressure gradient, to induce a delayed increase in PGE2 relative to PRE concentrations. Elevated concentrations of PGE2 have previously been shown to occur in inflamed and osteoarthritic joint tissues of horses [22, 38, 51, 87, 88]. Furthermore, these elevated prostaglandins may compromise the cartilage matrix by decreasing proteoglycan content [89, 90] as well as initiating a localized pain response via sensitization of peripheral nociceptor terminals [20]. In a previous study, increases in circulating proinflammatory cytokine transcripts (interleukin-1 beta) were detected 2 h following intense exhaustive treadmill exercise [6]. Interleukin-1 beta is a regulator of PGE2 release from joint tissues, which may also help explain why the increase in PGE2 is delayed past the 2 h POST sample in the current study. It is unknown if this was a transient increase, or if PGE2 levels remained elevated for a sustained period of time as sampling was not carried out past 24 h POST. The resting and postexercise PGE2 concentrations were higher in the current study compared to previous reports in horses [22], which might be attributable to different analytical techniques (extraction of PGE2 from SF versus evaluation of concentrations in diluted synovial fluid).
The increase in synovial fluid concentrations of CS at 30 min POST, which declined back to pre-exercise levels by 2 h POST in the exercise trial, suggests a transient increase in aggrecan synthesis. The magnitude of change from pre- to postexercise samples in the exercise trial was similar to that reported in chronically exercised horses [22]. Furthermore, absolute concentrations of CS in the present study were lower than those reported in the same chronically exercised healthy horses and in horses with clinical osteoarthritis [22]. When magnitude of change from to and 2 h POST to 24 h POST were compared between the preliminary and exercise trials, respectively, the increase in CS was 2.6 times greater in the exercise trial. Furthermore, absolute concentrations of CS were approximately 2057 ng mL−1 higher for the 2 h POST sample in the exercise trial compared to the sample in the preliminary trial. This data suggests that the RSET did elicit changes in cartilage turnover, most likely in response to cyclic high compressive loading [9195]. Several other studies have reported exercise-induced changes in cartilage metabolism. At the end of a 6 wk training study in horses, investigators reported an increase in newly synthesized proteoglycan from an ex vivo cartilage culture when compared to cartilage from nonexercised controls [96]. Another study reported a decrease in aggrecan synthesis and concomitant increase in decorin synthesis in equine cartilage explants that persisted for 16 wks of rest following 17 wks of strenuous exercise [97]. Increases in CS and keratin sulfate (catabolic marker of cartilage metabolism) have been associated with cases of osteochondral fragmentation in horses [24] and repetitive exercise over time [22, 98]. Healthy horses seem to be able to return to homeostatic conditions in joint tissues fairly quickly as was the case in the present study. However, if this modality and intensity of exercise were repeated over time without sufficient recovery periods, it could result in a chronic degenerative state, ultimately compromising the stability and functionality of the articular cartilage. Although it is difficult to determine whether the increase in synovial fluid CS concentrations at 24 h POST in the exercise trial is an artifact of repeated arthrocentesis, as was identified in the preliminary study, or a response to exercise, the possibility that the delayed increase in PGE2 following exercise may have contributed to the mild increase in aggrecan turnover, should not be completely discounted. Significant associations between serum and synovial fluid biomarkers of cartilage metabolism have been reported [22]; however, the same associations were not detected in the exercise trial.
Synovial fluid concentrations of both PGE2 and CS were higher in hock joints when compared to carpal joints in the exercise trial. This finding is in accord with a previous study which found higher concentration of nitric oxide in hock joints compared to that of carpus samples from mature healthy Standardbred mares [6]. The differences between hock and carpus joints in the present study may be attributable to conformational and biomechanical features unique to Standardbred trotters or pacers, with a higher degree of dynamic compressive and shear stress occurring in the hock joints. Another study also demonstrated increased nitric oxide synthesis in response to shear stress in bovine articular chondrocytes in culture, which in turn mediated an increase in GAG synthesis [99]. It has previously been reported [100] that 14.3% of 753 young Standardbred trotters sampled were diagnosed with osteochondrosis in the tibiotarsal joint and 11.8% were diagnosed with bony fragments in the palmar/plantar portion of the metacarpo and metatarsophalangeal joints. These data provide further evidence that Standardbreds, compared to other breeds, experience more exercise-induced stress in the hock joints compared to joints in the forelimbs and should be considered in light of athletic conditioning and rehabilitation programs.

4.3. Effect of Nutritional Supplementation

It was hypothesized that SOD supplementation in horses would mirror the beneficial findings reported in the literature demonstrating oral bioavailability [29, 30, 101] and subsequent benefits including anti-inflammatory [102, 103], antioxidant [104, 105], and chondroprotective properties [34, 106, 107] reported in several other animal models. Data from a porcine ischemia reperfusion injury model [105] and a human hyperbaric oxygen oxidative stress model [108] suggested that supplementation of a vegetal preparation of SOD combined with a wheat-gliadin biopolymer (SOD/gliadin) is protective against oxidative DNA damage and decreases markers of lipid peroxidation in circulation. Mice supplemented with SOD/gliadin for 28 d showed a rise in circulating antioxidant enzyme activity which was positively correlated with an increased erythrocyte resistance to oxidative induced hemolysis. This study also found increases in hepatic antioxidant defenses which were correlated with a significant decrease in hepatocyte apoptosis in the presence of Sin-1 (peroxynitrite chemical donor) when compared to controls [29]. In another study, peritoneal macrophages activated by an intraperitoneal injection of IFNγ, collected from mice after a 28 day supplementation of SOD/gliadin, and stimulated with IgG1IC ex vivo, exhibited a reduction in TNFα production and elevated IL-10 production as well as decreased superoxide, NO, and peroxynitrite concentrations [102].

In human studies, supplementation of SOD/gliadin in soccer athletes has been shown to reduce oxidative stress. Specifically, a decrease in the magnitude of 8-iso PGF2α response was observed in the experimental group following a graded step-wise exhaustive treadmill exercise test [30]. Similarly, college football athletes supplemented with a proprietary nutraceutical drink blend containing SOD, coenzyme Q10 and beta glucans during a 7-wk training period demonstrated anti-inflammatory (reduced IL-6), antioxidant (reduced 8-iso PGF2α), and less muscle membrane leakage of CK both after acute and chronic bouts of exercise compared to nonsupplemented controls [103]. Lastly, in patients with HIV or AIDs exhibiting compromised antioxidant status, it was determined that SOD/gliadin (1000 IU d−1) supplementation for 3 wks normalized the patients’ circulating SOD activity and total antioxidant status (TAS), demonstrating that oral supplementation with vegetal SOD supplement can improve systemic antioxidant defenses [104]. A previous study examining aspects of joint health demonstrated that addition of SOD to bovine synovial fluid was protective against hyaluronic acid depolymerization by superoxide derived hydroxyl radicals in vitro, thereby preserving the viscoelastic properties characteristic of healthy synovial fluid [106]. Palosein (generic name Orgotein), an FDA-approved, injectable form of a Cu-Zn protein with high-SOD enzyme activity derived from bovine liver [33], has also been shown to ameliorate free radical-induced (superoxide) loss in synovial fluid viscosity in horses [34]. Contrary to these reports, data from the present study suggest that supplemental SOD has no effect on biomarkers of inflammatory response, antioxidant status, or joint health in an equine exercise model.

Several factors may have contributed to the ineffectiveness of SOD supplementation in equine exercise model used in the exercise trial. The SOD may not have been effectively delivered to the target tissue, or the enzyme activity may have been compromised in the digestive and/or absorption processes. Historically, intravenous administration of SOD was the most common route of delivery, but therapeutic capabilities were limited due to its short half-life of less than 30 min [109]. Oral administration of SOD is a newer practice and the use of delivery technologies is a growing area of interest. The gliadin coating used in the present study is a hydrophobic gliadin-biopolymer demonstrated to be an effective carrier for oral delivery of active food ingredients, specifically lipophilic molecules [110]. Gliadin biopolymer has been shown to enhance oral pharmacology of SOD [111] delaying enzyme release thereby preserving the enzyme activity throughout the gastrointestinal (GI) tract as well as purportedly increasing intestinal permeability via increased zonulin release which opens the enterocyte tight junctions [112, 113]. It has been demonstrated that the SOD enzyme requires protection during GI transit [29]. Failure of SOD efficacy in the present study may be due to the gliadin biopolymer releasing the active ingredient at an inappropriate time during GI transit, rendering it incapable of being absorbed into circulation. Previous studies have investigated the biodegradation of Gliadin bioadhesion properties, pharmacokinetic properties, and active ingredient stability of various products [114, 115]. Subsequent studies should take these into consideration for the target species studied.

Failure of the oral SOD formulation to elicit increases in erythrocyte SOD activity may have been due to dosing rate. In the present study, 3000 IU d−1 SOD was fed at an average rate of 5.84 ± 0.18 IU kg bw−1 d−1 to the research mares. A similar SOD preparation was fed to pigs at rates of 0.316 and 1.2 IU kg bw−1 d−1 which allegedly resulted in 25% and 41% increases in plasma SOD activity, respectively [116]. In dogs, SOD has been supplemented at the rate of approximately 10 IU kg bw−1 d−1 [116], and mice have received SOD supplement at the rate of 0.003 IU kg bw−1 d−1 [29]. Although the horses in the present study were fed at a substantially higher rate than the other species, this dose could be insufficient and future research in horses should investigate different supplementation rates in excess of 3000 IU d−1.

Furthermore, an unfit animal model was thought to be more susceptible to tissue microdamage, inflammation, and oxidative stress resulting from the RSET compared to that of a physically fit model conditioned to a specific modality of exercise. This unfit model theoretically would have experienced the greatest benefit from SOD supplementation when compared to a fit, conditioned individual who might be better able to cope with exercise-induced ROS formation and inflammation, as previously demonstrated in horses and humans [30, 56, 117, 118]. Despite their healthy but unfit status, endogenous antioxidant defenses of the horses used in the present study appear to have been sufficient to handle the magnitude of oxidant stress relative to the RSET, therefore, rendering any benefits of exogenous SOD supplementation undetectable.

5. Conclusion

Repeated arthrocentesis within a 48 h time frame did not seem to influence PGE2 whereas CS concentrations did increase in joints of healthy mature horses in the present study. Therefore, impact of sampling techniques, exclusive to any treatment effects, should be evaluated and considered in the experimental design and subsequent data interpretation. Fluctuations in biomarkers of inflammation, antioxidant status, or aggrecan synthesis were not altered by SOD supplementation in Standardbred mares having undergone intense exercise in the present study. The RSET did result in a proinflammatory response as well as up-regulated antioxidant defenses, which suggests that it is an appropriate exercise modality for investigating systemic inflammatory responses and antioxidant status and oxidative stress in horses. The use of intense treadmill exercise to induce inflammation provides a realistic yet controlled, repeatable, and relatively noninvasive model of inflammation and joint metabolism under dynamic physiologic stress. The inflammatory and metabolic changes detected in synovial fluid in the exercise trial are thought to be normal physiological responses to a single bout of intense exercise. These data suggest that joint health in mature healthy horses is not compromised following a single intense bout of exhaustive exercise. However, repetitive exercise at this intensity, without sufficient recovery periods could result in sustained localized joint inflammation resulting in a chronic degenerative state. Oral supplements may provide practical solutions to support optimal health, performance, and the prevention of chronic disease in a variety of athletic species. Despite previous evidence of SOD efficacy in other species, further investigation is needed to elucidate benefit(s) of SOD supplementation and effective supplement delivery technologies in horses.


The authors would like to acknowledge the New Jersey Agricultural Experiment Station State Equine Initiative for partial funding of this study as well as the Rutgers University Animal Science Department undergraduate student research group and Animal Care staff. Lastly, a special thanks are due to Dr. Elizabeth O’Byrne (Rutgers University), Dr. David Horohov (University of Kentucky, Gluck Equine Research Center), Dr. Amy O. Burk and Tim Shellem (University of Maryland), and Drs. Michael Orth and Cara Robison (Michigan State University) for their help with sample analysis.


  1. D. E. Auer, J. C. Ng, J. Hrdlicka, and A. A. Seawright, “The elimination of injected superoxide dismutase from synovial fluid of the horse,” Australian Veterinary Journal, vol. 66, no. 4, pp. 117–119, 1989. View at: Google Scholar
  2. A. L. Bertone, J. L. Palmer, and J. Jones, “Synovial fluid cytokines and eicosanoids as markers of joint disease in horses,” Veterinary Surgery, vol. 30, no. 6, pp. 528–538, 2001. View at: Publisher Site | Google Scholar
  3. H. H. Petersen, J. P. Nielsen, and P. M. H. Heegaard, “Application of acute phase protein measurements in veterinary clinical chemistry,” Veterinary Research, vol. 35, no. 2, pp. 163–187, 2004. View at: Publisher Site | Google Scholar
  4. E. C. Firth, “The response of bone, articular cartilage and tendon to exercise in the horse,” Journal of Anatomy, vol. 208, no. 4, pp. 513–526, 2006. View at: Publisher Site | Google Scholar
  5. J. M. Streltsova, K. H. McKeever, N. R. Liburt et al., “Effect of orange peel and black tea extracts on markers of performance and cytokine markers of inflammation,” Equine and Comparative Exercise Physiology, vol. 2006, pp. 121–130, 2006. View at: Publisher Site | Google Scholar
  6. E. D. Lamprecht, C. A. Bagnell, and C. A. Williams, “Inflammatory responses to three modes of intense exercise in Standardbred mares-A pilot study,” Comparative Exercise Physiology, vol. 5, pp. 115–125, 2009. View at: Publisher Site | Google Scholar
  7. J. D. Lang, P. J. McArdle, P. J. O'Reilly, and S. Matalon, “Oxidant-antioxidant balance in acute lung injury,” Chest, vol. 122, no. 6, pp. 314S–320S, 2002. View at: Google Scholar
  8. N. Ishida, S. Hobo, T. Takahashi et al., “Chronological changes in superoxide-scavenging ability and lipid peroxide concentration of equine serum due to stress from exercise and transport,” Equine Veterinary Journal. Supplement, vol. 30, pp. 430–433, 1999. View at: Google Scholar
  9. A. White, M. Estrada, K. Walker et al., “Role of exercise and ascorbate on plasma antioxidant capacity in thoroughbred race horses,” Comparative Biochemistry and Physiology, vol. 128, no. 1, pp. 99–104, 2001. View at: Publisher Site | Google Scholar
  10. D. J. Marlin, K. Fenn, N. Smith et al., “Changes in circulatory antioxidant status in horses during prolonged exercise,” Journal of Nutrition, vol. 132, no. 6, pp. 1622S–1627S, 2002. View at: Google Scholar
  11. C. A. Williams, D. S. Kronfeld, T. M. Hess, K. E. Saker, and P. A. Harris, “Lipoic acid and vitamin E supplementation to horses diminishes endurance exercise induced oxidative stress, muscle enzyme leakage, and apoptosis. Page 105 in The Elite Race and Endurance Horse,” in Proceedings of the Equine Sports Medicine and Science, A. Lindner, Ed., Oslo, Norway, 2004. View at: Google Scholar
  12. S. Kinnunen, S. Hyyppä, A. Lehmuskero et al., “Oxygen radical absorbance capacity (ORAC) and exercise-induced oxidative stress in trotters,” European Journal of Applied Physiology, vol. 95, no. 5-6, pp. 550–556, 2005. View at: Publisher Site | Google Scholar
  13. P. N. Shek, B. H. Sabiston, A. Buguet, and M. W. Radomski, “Strenuous exercise and immunological changes: a multiple-time-point analysis of leukocyte subsets, CD4/CD8 ratio, immunoglobulin production and NK cell response,” International Journal of Sports Medicine, vol. 16, no. 7, pp. 466–474, 1995. View at: Publisher Site | Google Scholar
  14. I. K. M. Brenner, V. M. Natale, P. Vasiliou, A. I. Moldoveanu, P. N. Shek, and R. J. Shephard, “Impact of three different types of exercise on components of the inflammatory response,” European Journal of Applied Physiology and Occupational Physiology, vol. 80, no. 5, pp. 452–460, 1999. View at: Publisher Site | Google Scholar
  15. P. D. Rossdale, R. Hopes, N. J. Digby, and K. offord, “Epidemiological study of wastage among racehorses 1982 and 1983,” Veterinary Record, vol. 116, no. 3, pp. 66–69, 1985. View at: Google Scholar
  16. J. A. Kidd, C. Fuller, and A. R. S. Barr, “Osteoarthritis in the horse,” Equine Veterinary Education, vol. 13, no. 3, pp. 160–168, 2001. View at: Google Scholar
  17. USDA, Lameness and Laminitis in U.S. Horses. USDA:APHIS:VS, CEAH, National Animal Health Monitoring System. #N348.1001 USDA, Fort Collins, Colo, USA, 2001.
  18. P. K. Dyson, B. F. Jackson, D. U. Pfeiffer, and J. S. Price, “Days lost from training by two- and three-year-old Thoroughbred horses: a survey of seven UK training yards,” Equine Veterinary Journal, vol. 40, no. 7, pp. 650–657, 2008. View at: Publisher Site | Google Scholar
  19. B. von Rechenberg, C. W. McIlwraith, M. K. Akens, D. D. Frisbie, C. Leutenegger, and J. A. Auer, “Spontaneous production of nitric oxide (NO), prostaglandin (PGE2) and neutral metalloproteinases (NMPs) in media of explant cultures of equine synovial membrane and articular cartilage from normal and osteoarthritic joints,” Equine Veterinary Journal, vol. 32, no. 2, pp. 140–150, 2000. View at: Google Scholar
  20. E. V. Tchetina, J. A. Di Battista, D. J. Zukor, J. Antoniou, and A. R. Poole, “Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy,” Arthritis Research and Therapy, vol. 9, no. 4, article R75, 2007. View at: Publisher Site | Google Scholar
  21. C. W. McIlwraith, “Use of synovial fluid and serum biomarkers in equine bone and joint disease: a review,” Equine Veterinary Journal, vol. 37, no. 5, pp. 473–482, 2005. View at: Google Scholar
  22. D. D. Frisbie, F. Al-Sobayil, R. C. Billinghurst, C. E. Kawcak, and C. W. McIlwraith, “Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses,” Osteoarthritis and Cartilage, vol. 16, no. 10, pp. 1196–1204, 2008. View at: Publisher Site | Google Scholar
  23. A. R. Poole, M. Ionescu, A. Swan, and P. A. Dieppe, “Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis,” Journal of Clinical Investigation, vol. 94, no. 1, pp. 25–33, 1994. View at: Google Scholar
  24. D. D. Frisbie, C. S. Ray, M. Ionescu, A. R. Poole, P. L. Chapman, and C. W. McIlwraith, “Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses,” American Journal of Veterinary Research, vol. 60, no. 3, pp. 306–309, 1999. View at: Google Scholar
  25. L. A. Fortier, “Systemic therapies for joint disease in horses,” Veterinary Clinics of North America, vol. 21, no. 3, pp. 547–557, 2005. View at: Publisher Site | Google Scholar
  26. S. K. Nelson, S. K. Bose, G. K. Grunwald, P. Myhill, and J. M. McCord, “The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy,” Free Radical Biology and Medicine, vol. 40, no. 2, pp. 341–347, 2006. View at: Publisher Site | Google Scholar
  27. S. Cuzzocrea, E. Mazzon, L. Dugo, A. P. Caputi, D. P. Riley, and D. Salvemini, “Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis,” European Journal of Pharmacology, vol. 432, no. 1, pp. 79–89, 2001. View at: Publisher Site | Google Scholar
  28. E. Masini, S. Cuzzocrea, E. Mazzon, C. Marzocca, P. F. Mannaioni, and D. Salvemini, “Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo,” British Journal of Pharmacology, vol. 136, no. 6, pp. 905–917, 2002. View at: Publisher Site | Google Scholar
  29. I. Vouldoukis, M. Conti, P. Krauss et al., “Supplementation with gliadin-combined plant superoxide dismutase extract promotes antioxidant defences and protects against oxidative stress,” Phytotherapy Research, vol. 18, no. 12, pp. 957–962, 2004. View at: Publisher Site | Google Scholar
  30. S. M. Arent, P. Davitt, D. L. Golem, C. A. Williams, K. H. McKeever, and C. Jaouhari, “The effects of a post-workout nutraceutical drink on body composition, performance and hormonal and biochemical responses in Division I college football players,” Comparative Exercise Physiology, vol. 6, pp. 73–80, 2009. View at: Google Scholar
  31. S. M. Arent, J. K. Pellegrino, C. A. Williams, D. A. Difabio, and J. C. Greenwood, “Nutritional supplementation, performance, and oxidative stress in college soccer players,” Journal of Strength and Conditioning Research, vol. 24, no. 4, pp. 1117–1124, 2010. View at: Publisher Site | Google Scholar
  32. M. Petelin, Z. Pavlica, T. Ivanuša, M. Šentjurc, and U. Skalerič, “Local delivery of liposome-encapsulated superoxide dismutase and catalase suppress periodontal inflammation in beagles,” Journal of Clinical Periodontology, vol. 27, no. 12, pp. 918–925, 2000. View at: Google Scholar
  33. W. Huber, “Orgotein-(bovine Cu-Zn superoxide dismutase), an anti-inflammatory protein drug: discovery, toxicology and pharmacology,” European Journal of Rheumatology and Inflammation, vol. 4, no. 2, pp. 173–182, 1981. View at: Google Scholar
  34. D. E. Auer, J. C. Ng, and A. A. Seawright, “Effect of palosein (superoxide dismutase) and catalase upon oxygen derived free radical induced degradation of equine synovial fluid,” Equine Veterinary Journal, vol. 22, no. 1, pp. 13–17, 1990. View at: Google Scholar
  35. American Association of Equine Practitioners, Guide for Veterinary Service and Judging of Equestrian Events, 4th edition, 1991.
  36. D. R. Henneke, G. D. Potter, J. L. Kreider, and B. F. Yeates, “Relationship between condition score, physical measurements and body fat percentage in mares,” Equine Veterinary Journal, vol. 15, no. 4, pp. 371–372, 1983. View at: Google Scholar
  37. R. G. Westervelt, J. R. Stouffer, H. F. Hintz, and H. F. Schryver, “Estimating fatness in horses and ponies,” Journal of Animal Science, vol. 43, pp. 781–785, 1976. View at: Google Scholar
  38. R. Y. Au, T. K. Al-Talib, A. Y. Au, P. V. Phan, and C. G. Frondoza, “Avocado soybean unsaponifiables (ASU) suppress TNF-α, IL-1β, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages,” Osteoarthritis and Cartilage, vol. 15, no. 11, pp. 1249–1255, 2007. View at: Publisher Site | Google Scholar
  39. C. Beauchamp and I. Fridovich, “Superoxide dismutase: improved assays and an assay applicable to acrylamide gels,” Analytical Biochemistry, vol. 44, no. 1, pp. 276–287, 1971. View at: Google Scholar
  40. P. M. Graham-Thiers, D. S. Kronfeld, K. A. Kline, D. J. Sklan, and P. A. Harris, “Dietary protein and fat effects on protein status in arabian horses during interval training and repeated sprints,” Journal of Equine Veterinary Science, vol. 23, no. 12, pp. 554–559, 2003. View at: Publisher Site | Google Scholar
  41. J. A. Wilson, D. S. Kronfeld, L. S. Gay, J. H. Williams, T. M. Wilson, and M. I. Lindinger, “Sarcoplasmic reticulum responses to repeated sprints are affected by conditioning of horses,” Journal of Animal Science, vol. 76, no. 12, pp. 3065–3071, 1998. View at: Google Scholar
  42. K. Hasegawa, S. Wakino, S. Tatematsu et al., “Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2,” Circulation Research, vol. 101, no. 2, pp. e2–e10, 2007. View at: Publisher Site | Google Scholar
  43. R. J. Cybulski, P. Sanz, F. Alem, S. Stibitz, R. L. Bull, and A. D. O'Brien, “Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress,” Infection and Immunity, vol. 77, no. 1, pp. 274–285, 2009. View at: Publisher Site | Google Scholar
  44. Z. Qin, M. Karabiyikoglu, Y. Hua et al., “Hyperbaric oxygen-induced attenuation of hemorrhagic transformation after experimental focal transient cerebral ischemia,” Stroke, vol. 38, no. 4, pp. 1362–1367, 2007. View at: Publisher Site | Google Scholar
  45. F. M. Maiorino, R. Brigelius-Flohé, K. D. Aumann, A. Roveri, D. Schomburg, and L. Flohé, “Diversity of glutathione peroxidases,” Methods in Enzymology, vol. 252, pp. 38–53, 1995. View at: Publisher Site | Google Scholar
  46. J. P. Richie, L. Skowronski, P. Abraham, and Y. Leutzinger, “Blood glutathione concentrations in a large-scale human study,” Clinical Chemistry, vol. 42, no. 1, pp. 64–70, 1996. View at: Google Scholar
  47. M. M. Vick, A. A. Adams, B. A. Murphy et al., “Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse,” Journal of Animal Science, vol. 85, no. 5, pp. 1144–1155, 2007. View at: Publisher Site | Google Scholar
  48. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at: Publisher Site | Google Scholar
  49. D. M. Ainsworth, J. A. Appleton, S. W. Eicker, R. Luce, M. J. Flaminio, and D. F. Antczak, “The effect of strenuous exercise on mRNA concentrations of interleukin-12, interferon-gamma and interleukin-4 in equine pulmonary and peripheral blood mononuclear cells,” Veterinary Immunology and Immunopathology, vol. 91, no. 1, pp. 61–71, 2003. View at: Publisher Site | Google Scholar
  50. C. Ramakers, J. M. Ruijter, R. H. Lekanne Deprez, and A. F. M. Moorman, “Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data,” Neuroscience Letters, vol. 339, no. 1, pp. 62–66, 2003. View at: Publisher Site | Google Scholar
  51. R. van den Boom, C. H. A. van de Lest, S. Bull, P. A. J. Brama, P. R. van Weeren, and A. Barneveld, “Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints,” Equine Veterinary Journal, vol. 37, no. 3, pp. 250–256, 2005. View at: Google Scholar
  52. P. A. J. Brama, R. van den Boom, J. DeGroot, G. H. Kiers, and P. R. van Weeren, “Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis,” Equine Veterinary Journal, vol. 36, no. 1, pp. 34–40, 2004. View at: Google Scholar
  53. R. van den Boom, P. A. J. Brama, G. H. Kiers, J. DeGroot, A. Barneveld, and P. R. Van Weeren, “The influence of repeated arthrocentesis and exercise on matrix metalloproteinase and tumour necrosis factor α activities in normal equine joints,” Equine Veterinary Journal, vol. 36, no. 2, pp. 155–159, 2004. View at: Google Scholar
  54. F. C. Robion, B. Doizé, L. Bouré et al., “Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo,” Journal of Orthopaedic Research, vol. 19, no. 2, pp. 250–258, 2001. View at: Publisher Site | Google Scholar
  55. A. Szucsik, V. Baliskonis, and K. H. McKeever, “Effect of seven common supplements on plasma electrolyte and total carbon dioxide concentration and strong ion difference in Standardbred horses subjected to a simulated race test,” Equine and Comparative Exercise Physiology, vol. 3, pp. 37–44, 2006. View at: Publisher Site | Google Scholar
  56. C. A. Williams, M. E. Gordon, C. L. Betros, and K. H. McKeever, “Apoptosis and antioxidant status are influenced by age and exercise training in horses,” Journal of Animal Science, vol. 86, no. 3, pp. 576–583, 2008. View at: Publisher Site | Google Scholar
  57. B. Padalino, G. Rubino, P. Centoducati, and F. Petazzi, “Training versus overtraining: evaluation of two protocols,” Journal of Equine Veterinary Science, vol. 27, no. 1, pp. 28–31, 2007. View at: Publisher Site | Google Scholar
  58. P. A. Harris, “Musculoskeletal disease,” in Equine Internal Medicine, S. M. Reed and W. M. Bayly, Eds., pp. 375–397, WB Saunders, 1998. View at: Google Scholar
  59. A. Frankiewicz-Jóźko and E. Szarska, “Anti-oxidant level to exercise in the blood of endurance horses,” Biology of Sport, vol. 17, no. 3, pp. 217–227, 2000. View at: Google Scholar
  60. C. A. Williams, D. S. Kronfeld, T. M. Hess et al., “Comparison of oxidative stress and antioxidant status in endurance horses in three 80-km races,” Equine and Comparative Exercise Physiology, vol. 2, pp. 153–157, 2004. View at: Google Scholar
  61. J. M. McBride and W. J. Kraemer, “Effect of vitamin E status on lipid peroxidation in exercised horses,” The Journal of Strength & Conditioning Research, vol. 13, pp. 175–183, 1999. View at: Google Scholar
  62. A. I. Moldoveanu, R. J. Shephard, and P. N. Shek, “The cytokine response to physical activity and training,” Sports Medicine, vol. 31, no. 2, pp. 115–144, 2001. View at: Google Scholar
  63. J. J. Haddad and C. S. Fahlman, “Redox- and oxidant-mediated regulation of interleukin-10: an anti-inflammatory, antioxidant cytokine?” Biochemical and Biophysical Research Communications, vol. 297, no. 2, pp. 163–176, 2002. View at: Publisher Site | Google Scholar
  64. A. Oberholzer, C. Oberholzer, and L. L. Moldawer, “Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug,” Critical Care Medicine, vol. 30, no. 1, pp. S58–S63, 2002. View at: Google Scholar
  65. R. Pezzilli, P. Billi, R. Miniero, and B. Barakat, “Serum interleukin-10 in human acute pancreatitis,” Digestive Diseases and Sciences, vol. 42, no. 7, pp. 1469–1472, 1997. View at: Publisher Site | Google Scholar
  66. C. A. Gunnett, D. D. Heistad, D. J. Berg, and F. M. Faraci, “IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation,” American Journal of Physiology, vol. 279, no. 4, pp. H1555–H1562, 2000. View at: Google Scholar
  67. M. A. Gougerot-Podicalo, C. Elbim, and S. Chollet-Martin, “Modulation by pro- and anti-inflammatory cytokines of the oxidative burst of human neutrophils,” Pathologie Biologie, vol. 44, no. 1, pp. 36–41, 1996. View at: Google Scholar
  68. S. S. Chen, J. Gong, L. F-T, and U. Mohammed, “Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation,” Immunology, vol. 100, no. 4, pp. 471–480, 2000. View at: Publisher Site | Google Scholar
  69. Y. Hong, S. Hong, Y. H. Chang, and S. H. Cho, “Influence of an orally effective superoxide dismutase (Glisodin) on strenuous exercise-induced changes of blood antioxidant enzymes and plasma lactate,” in Proceedings of the American Association for Clinical Chemistry. National Meeting-Poster, Los Angeles, Calif, USA, 2004. View at: Google Scholar
  70. R. J. Bloomer, “Effect of exercise on oxidative stress biomarkers,” Advances in Clinical Chemistry, vol. 46, pp. 1–50, 2008. View at: Publisher Site | Google Scholar
  71. H. Andersson, A. Karlsen, R. Blomhoff, T. Raastad, and F. Kadi, “Plasma antioxidant responses and oxidative stress following a soccer game in elite female players,” Scandinavian Journal of Medicine and Science in Sports, vol. 20, no. 4, pp. 600–608, 2010. View at: Publisher Site | Google Scholar
  72. P. C. Mills, “Effects of exercise intensity and environmental stress on indices of oxidative stress and iron homeostasis during exercise in the horse,” European Journal of Applied Physiology and Occupational Physiology, vol. 74, no. 1-2, pp. 60–66, 1996. View at: Google Scholar
  73. E. Chiaradia, L. Avellini, F. Rueca et al., “Physical exercise, oxidative stress and muscle damage in racehorses,” Comparative Biochemistry and Physiology B, vol. 119, no. 4, pp. 833–836, 1998. View at: Publisher Site | Google Scholar
  74. C. A. Williams and S. A. Carlucci, “Oral vitamin E supplementation on oxidative stress, vitamin and antioxidant status in intensely exercised horses,” Equine Veterinary Journal. Supplement, no. 36, pp. 617–621, 2006. View at: Google Scholar
  75. D. C. Donovan, C. A. Jackson, P. T. Colahan et al., “Assessment of exercise-induced alterations in neutrophil function in horses,” American Journal of Veterinary Research, vol. 68, no. 11, pp. 1198–1204, 2007. View at: Publisher Site | Google Scholar
  76. Li Li Ji and R. Fu, “Responses of glutathione system and antioxidant enzymes to exhaustive exercise and hydroperoxide,” Journal of Applied Physiology, vol. 72, no. 2, pp. 549–554, 1992. View at: Google Scholar
  77. K. Sahlin, K. Ekberg, and S. Cizinsky, “Changes in plasma hypoxanthine and free radical markers during exercise in man,” Acta Physiologica Scandinavica, vol. 142, no. 2, pp. 275–281, 1991. View at: Google Scholar
  78. K. Ono, K. Inui, T. Hasegawa et al., “The changes of antioxidative enzyme activities in equine erythrocytes following exercise,” The Japanese Journal of Veterinary Science, vol. 52, no. 4, pp. 759–765, 1990. View at: Google Scholar
  79. B. J. Hargreaves, D. S. Kronfeld, J. N. Waldron et al., “Antioxidant status of horses during two 80-km endurance races,” Journal of Nutrition, vol. 132, no. 6, pp. 1781S–1783S, 2002. View at: Google Scholar
  80. A. M. Niess, H. H. Dickhuth, H. Northoff, and E. Fehrenbach, “Free radicals and oxidative stress in exercise-immunological aspects,” Exercise Immunology Review, no. 5, pp. 22–56, 1999. View at: Google Scholar
  81. D. C. Donovan, C. A. Jackson, P. T. Colahan, N. Norton, and D. J. Hurley, “Exercise-induced alterations in pro-inflammatory cytokines and prostaglandin F2α in horses,” Veterinary Immunology and Immunopathology, vol. 118, no. 3-4, pp. 263–269, 2007. View at: Publisher Site | Google Scholar
  82. A. Sureda, P. Tauler, A. Aguiló et al., “Blood cell NO synthesis in response to exercise,” Nitric Oxide, vol. 15, no. 1, pp. 5–12, 2006. View at: Publisher Site | Google Scholar
  83. R. L. Smith, M. C. D. Trindade, T. Ikenoue et al., “Effects of shear stress on articular chondrocyte metabolism,” Biorheology, vol. 37, no. 1-2, pp. 95–107, 2000. View at: Google Scholar
  84. R. L. Smith, B. S. Donlon, M. K. Gupta et al., “Effects of fluid-induced shear on articular chondrocyte morphology and metabolism in vitro,” Journal of Orthopaedic Research, vol. 13, no. 6, pp. 824–831, 1995. View at: Publisher Site | Google Scholar
  85. A. N. Dimock, P. D. Siciliano, and C. W. Mcilwraith, “Evidence supporting an increased presence of reactive oxygen species in the diseased equine joint,” Equine Veterinary Journal, vol. 32, no. 5, pp. 439–443, 2000. View at: Google Scholar
  86. R. A. Greenwald and W. W. Moy, “Inhibition of collagen gelation by action of the superoxide radical,” Arthritis and Rheumatism, vol. 22, no. 3, pp. 251–259, 1979. View at: Google Scholar
  87. S. May, R. Hooke, and K. Peremans, “Prostaglandin E2 in equine joint disease,” Vlaams Diergeneeskundig Tijdschrift, vol. 63, no. 6, pp. 187–191, 1994. View at: Google Scholar
  88. P. S. Chan, J. P. Caron, G. J. M. Rosa, and M. W. Orth, “Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants,” Osteoarthritis and Cartilage, vol. 13, no. 5, pp. 387–394, 2005. View at: Publisher Site | Google Scholar
  89. C. C. Teitz and O. D. Chrisman, “The effect of salicylate and chloroquine on prostaglandin induced articular damage in the rabbit knee,” Clinical Orthopaedics, vol. 108, pp. 264–274, 1975. View at: Google Scholar
  90. L. Lippiello, K. Yamamoto, D. Robinson, and H. J. Mankin, “Involvement of prostaglandins from rheumatoid synovium in inhibition of articular cartilage metabolism,” Arthritis and Rheumatism, vol. 21, no. 8, pp. 909–917, 1978. View at: Google Scholar
  91. M. J. Palmoski and K. D. Brandt, “Effects of static and cyclic compressive loading on articular cartilage plugs in vitro,” Arthritis and Rheumatism, vol. 27, no. 6, pp. 675–681, 1984. View at: Google Scholar
  92. R. L. Y. Sah, Y. J. Kim, J. Y. H. Doong, A. J. Grodzinsky, A. H. K. Plaas, and J. D. Sandy, “Biosynthetic response of cartilage explants to dynamic compression,” Journal of Orthopaedic Research, vol. 7, no. 5, pp. 619–636, 1989. View at: Google Scholar
  93. J. J. Parkkinen, J. Ikonen, M. J. Lammi, J. Laakkonen, M. Tammi, and H. J. Helminen, “Effects of cyclic hydrostatic pressure on proteoglycan synthesis in cultured chondrocytes and articular cartilage explants,” Archives of Biochemistry and Biophysics, vol. 300, no. 1, pp. 458–465, 1993. View at: Publisher Site | Google Scholar
  94. M. D. Buschmann, Y. J. Kim, M. Wong, E. Frank, E. B. Hunziker, and A. J. Grodzinsky, “Stimulation of aggrecan synthesis in cartilage explants by cyclic loading is localized to regions of high interstitial fluid flow,” Archives of Biochemistry and Biophysics, vol. 366, no. 1, pp. 1–7, 1999. View at: Publisher Site | Google Scholar
  95. E. H. Frank, M. Jin, A. M. Loening, M. E. Levenston, and A. J. Grodzinsky, “A versatile shear and compression apparatus for mechanical stimulation of tissue culture explants,” Journal of Biomechanics, vol. 33, no. 11, pp. 1523–1527, 2000. View at: Publisher Site | Google Scholar
  96. J. L. Palmer, A. L. Bertone, C. J. Malemud, B. G. Carter, R. S. Papay, and J. Mansour, “Site-specific proteoglycan characteristics of third carpal articular cartilage in exercised and nonexercised horses,” American Journal of Veterinary Research, vol. 56, no. 12, pp. 1570–1576, 1995. View at: Google Scholar
  97. C. B. Little, P. Ghosh, and R. Rose, “The effect of strenuous versus moderate exercise on the metabolism of proteoglycans in articular cartilage from different weight-bearing regions of the equine third carpal bone,” Osteoarthritis and Cartilage, vol. 5, no. 3, pp. 161–172, 1997. View at: Publisher Site | Google Scholar
  98. M. Okumura, G. H. Kim, M. Tagami, S. Haramaki, and T. Fujinaga, “Serum Keratan sulphate as a cartilage metabolic marker in horses: the effect of exercise,” Journal of Veterinary Medicine A, vol. 49, no. 4, pp. 195–197, 2002. View at: Google Scholar
  99. P. Das, D. J. Schurman, and R. L. Smith, “Nitric oxide and G proteins mediate the response of bovine articular chondrocytes to fluid-induced shear,” Journal of Orthopaedic Research, vol. 15, no. 1, pp. 87–93, 1997. View at: Publisher Site | Google Scholar
  100. A. M. Grøndahl and N. I. Dolvik, “Heritability estimations of osteochondrosis in the tibiotarsal joint and of bony fragments in the palmar/plantar portion of the metacarpo- and metatarsophalangeal joints of horses,” Journal of the American Veterinary Medical Association, vol. 203, no. 1, pp. 101–104, 1993. View at: Google Scholar
  101. C. B. Webb, T. L. Lehman, and K. W. McCord, “Effects of an oral superoxide dismutase enzyme supplementation on indices of oxidative stress, proviral load, and CD4:CD8 ratios in asymptomatic FIV-infected cats,” Journal of Feline Medicine and Surgery, vol. 10, no. 5, pp. 423–430, 2008. View at: Publisher Site | Google Scholar
  102. I. Vouldoukis, D. Lacan, C. Kamate et al., “Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity,” Journal of Ethnopharmacology, vol. 94, no. 1, pp. 67–75, 2004. View at: Publisher Site | Google Scholar
  103. S. M. Arent, J. Pellegrino, K. H. McKeever et al., “Nutritional supplementation, body composition, performance, and hormonal responses in division I college football players,” Medicine and Science in Sports and Exercise. Supplement, vol. 5, p. S361, 2007. View at: Google Scholar
  104. H. Chenal, A. Davit-Spraul, J. Brevet et al., “The effects of an orally effective SOD on AIDS West African patients in a randomized double-blinded clinical study,” in Proceedings of the XVI International AIDS Conference, no. CDB0865, Toronto, Canada, 2006. View at: Google Scholar
  105. J. Kick, B. Hauser, H. Bracht et al., “Effects of a cantaloupe melon extract/wheat gliadin biopolymer during aortic cross-clamping,” Intensive Care Medicine, vol. 33, no. 4, pp. 694–702, 2007. View at: Publisher Site | Google Scholar
  106. J. M. McCord, “Free radicals and inflammation: protection of synovial fluid by superoxide dismutase,” Science, vol. 185, no. 4150, pp. 529–531, 1974. View at: Google Scholar
  107. W. H. Betts and L. G. Cleland, “Effect of metal chelators and antiinflammatory drugs on the degradation of hyaluronic acid,” Arthritis and Rheumatism, vol. 25, no. 12, pp. 1469–1476, 1982. View at: Google Scholar
  108. C. M. Muth, Y. Glenz, M. Klaus, P. Radermacher, G. Speit, and X. Leverve, “Influence of an orally effective SOD on hyperbaric oxygen-related cell damage,” Free Radical Research, vol. 38, no. 9, pp. 927–932, 2004. View at: Publisher Site | Google Scholar
  109. A. Baret, G. Jadot, and A. M. Michelson, “Pharmacokinetic and anti-inflammatory properties in the rat of superoxide dismutases (Cu SODs and Mn SOD) from various species,” Biochemical Pharmacology, vol. 33, no. 17, pp. 2755–2760, 1984. View at: Publisher Site | Google Scholar
  110. M. A. Arangoa, M. A. Campanero, M. J. Renedo, G. Ponchel, and J. M. Irache, “Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics,” Pharmaceutical Research, vol. 18, no. 11, pp. 1521–1527, 2001. View at: Publisher Site | Google Scholar
  111. B. Dugas, “Glisodin: a nutraceutical product that promotes the oral delivery of superoxide dismutase,” Free Radical Biology and Medicine, vol. 33, p. S64, 2002. View at: Google Scholar
  112. M. G. Clemente, S. De Virgiliis, J. S. Kang et al., “Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function,” Gut, vol. 52, no. 2, pp. 218–223, 2003. View at: Publisher Site | Google Scholar
  113. S. Drago, R. El Asmar, M. Di Pierro et al., “Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines,” Scandinavian Journal of Gastroenterology, vol. 41, no. 4, pp. 408–419, 2006. View at: Publisher Site | Google Scholar
  114. V. Stella, P. Vallée, P. Albrecht, and E. Postaire, “Gliadin films. I: preparation and in vitro evaluation as a carrier for controlled drug release,” International Journal of Pharmaceutics, vol. 121, no. 1, pp. 117–121, 1995. View at: Publisher Site | Google Scholar
  115. M. A. Arangoa, G. Ponchel, A. M. Orecchioni, M. J. Renedo, D. Duchêne, and J. M. Irache, “Bioadhesive potential of gliadin nanoparticulate systems,” European Journal of Pharmaceutical Sciences, vol. 11, no. 4, pp. 333–341, 2000. View at: Publisher Site | Google Scholar
  116. Personal Communication, Dr. David Griffin, Nutramax Laboratories, Edgewood, Md, USA, 2012.
  117. S. K. Powers, L. L. Ji, and C. Leeuwenburgh, “Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review,” Medicine and Science in Sports and Exercise, vol. 31, no. 7, pp. 987–997, 1999. View at: Publisher Site | Google Scholar
  118. C. Kasapis and P. D. Thompson, “The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review,” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1563–1569, 2005. View at: Publisher Site | Google Scholar

Copyright © 2012 Emily D. Lamprecht and Carey A. Williams. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

2045 Views | 1419 Downloads | 15 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.